TickerFiles

Biofrontera Inc. 10-Q filing

Filed 2025-08-13 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001641172-25-023486
Form type
10-Q
CIK
0001858685
Primary document
https://www.sec.gov/Archives/edgar/data/1858685/000164117225023486/form10-q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Biofrontera Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$17.6M--
Operating Income$-9.6M--
Net Income$-9.5M--
Eps Basic-1.05--
Eps Diluted-1.05--
Cash And Equivalents$7.2M--
Total Assets$20.1M--
Total Liabilities$24.8M--
Shareholders Equity$-4.7M--
Operating Cash Flow$-7.2M--
Capital Expenditures$4,000--